WO2023042232 - EPISCLERAL IMPLANT FOR FILTERING SURGERY OF GLAUCOMA
National phase entry is expected:
Publication Number
WO/2023/042232
Publication Date
23.03.2023
International Application No.
PCT/IT2022/050247
International Filing Date
13.09.2022
Title **
[English]
EPISCLERAL IMPLANT FOR FILTERING SURGERY OF GLAUCOMA
[French]
IMPLANT ÉPISCLÉRAL POUR LE FILTRAGE DE LA CHIRURGIE DU GLAUCOME
Applicants **
LONGO, Antonio
Inventors
LONGO, Antonio
Priority Data
102021000023909
16.09.2021
IT
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1880 | |
| EPO | Filing, Examination, Granting | 6212 | |
| Japan | Filing, Examination, Granting | 1908 | |
| South Korea | Filing, Examination, Granting | 1569 | |
| USA | Filing, Examination, Granting | 6540 |
Total:
18,109
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
An episcleral implant for the treatment of glaucoma, to be used during trabeculectomy; having a concave base with holes, to be placed over the sclera, and an upper convex fenestrated structure, to be covered with conjunctiva; the base and the upper structure delimit a large inner empty space; made of soft biocompatible material, or alternatively of a shape memory material; to be placed at the superior margin of the scleral flap of the trabeculectomy, aiming to avoid the adhesion of the conjunctiva to the sclera, to maintain the diffusion of aqueous humor under the conjunctiva in large area. Supporting elements are present at the extremities for fixation to the sclera by sutures.[French]
L'invention concerne un implant épiscléral pour le traitement du glaucome, destiné à être utilisé pendant la trabéculectomie; ayant une base concave avec des trous, destinée à être placée sur la sclère, et une structure fenêtrée convexe supérieure, devant être recouverte de la conjonctive; la base et la structure supérieure délimitent un grand espace vide interne; l'implant étant réalisé dans un matériau biocompatible souple, ou en variante dans un matériau à mémoire de forme; à placer au niveau de la marge supérieure du rabat scléral de la trabéculectomie, pour éviter l'adhérence de la conjonctive à la sclère, afin de maintenir la diffusion de l'humeur aqueuse sous la conjonctive dans une large zone. Des éléments de support sont présents aux extrémités pour la fixation à la sclère par des fils sutures.